课题基金 / 基金详情

The Use of Extended Peri-operative Low Molecular Weight Heparin to Improve Cancer Specific Survival Following Surgical Resection of Colon Cancer: A Randomized Controlled Trial

The Use of Extended Peri-operative Low Molecular Weight Heparin to Improve Cancer Specific Survival Following Surgical Resection of Colon Cancer: A Randomized Controlled Trial
延长围手术期低分子量肝素的使用以提高结肠癌手术切除后的癌症特异性生存率：一项随机对照试验
批准号：
200970
负责人：
Carrier Marc
金额：
$59.46万
依托单位：
Ottawa Hospital Research Institute
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2010
资助国家：
加拿大
项目状态：
已结题
起止时间：
2010-03-01 至 2014-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=200970&lang=en
关键词：
Gastro-Intestinal Cancer Randomized Controlled Trial Survival Thromboprophylaxis

项目摘要

项目成果

Carrier Marc的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The human body has a natural stress response to surgery, including the fomation of blood clots. This response to surgery has been shown to increase metastases (the spread of cancer cells to other organs in the body). These metastases cannot be seen at the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Colchicine to Quench the Inflammatory Response after Deep Vein Thrombosis: A Pilot Randomized Controlled Trial - CONQUER-DVT Pilot Trial
  • 批准号：
    480053
  • 项目类别：
    Operating Grants
  • 资助金额：
    $27.31万
  • 财政年份：
    2023
  • 负责人：
    Carrier Marc
  • 依托单位：
    Ottawa Hospital Research Institute
Primary thromboprophylaxis with rivaroxaban in patients with malignancy and central venous catheters: TRIM-Line.
  • 批准号：
    434579
  • 项目类别：
    Operating Grants
  • 资助金额：
    $100.81万
  • 财政年份：
    2020
  • 负责人：
    Carrier Marc
  • 依托单位：
    Ottawa Hospital Research Institute
Screening for Previously Undiagnosed Cancer in Patients with Venous Thromboembolism
  • 批准号：
    178854
  • 项目类别：
    Randomized Controlled Trials
  • 资助金额：
    $10.2万
  • 财政年份：
    2009
  • 负责人：
    Carrier Marc
  • 依托单位：
    University of Ottawa
海外基金